ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
86 hedge funds and large institutions have $128M invested in Anthera Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 39 increasing their positions, 21 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
18% more funds holding
Funds holding: 73 → 86 (+13)
10% less capital invested
Capital invested by funds: $142M → $128M (-$13.5M)
Holders
86
Holding in Top 10
2
Calls
$3.29M
Puts
$2.27M
Top Buyers
| 1 | +$12.7M | |
| 2 | +$3.76M | |
| 3 | +$2.56M | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$2.17M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$2M |
Top Sellers
| 1 | -$2.25M | |
| 2 | -$1.53M | |
| 3 | -$1.44M | |
| 4 |
BC
Broadfin Capital
New York
|
-$1.31M |
| 5 |
PA
Perceptive Advisors
New York
|
-$1.1M |